2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

February 29, 2008

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Sodium Ferric Gluconate Complex

125 mg weekly x 8 weeks

DRUG

Sodium Ferric Gluconate Complex

250 mg weekly x 4

DRUG

Oral Iron

325 mg ferrous sulfate orally three times daily x 8 weeks

Trial Locations (43)

Unknown

Birmingham

Mesa

Los Angeles

Torrance

New Haven

Evanston

Shreveport

Springfield

Worcester

Royal Oak

St Louis

New York

Chapel Hill

Winston-Salem

Tulsa

Philadelphia

Sioux Falls

Dallas

Richmond

Sofia

Varna

Kelowna

Kitchener

London

Scarborough

Toronto

Zagreb

Bangalore

Chandigarh

Chennai

Hyderabad

Lucknow

Mahīm

New Delhi

Col. Toriello Guerra

Durango

Mexico City

Monterrey

Tlalpan

Zapopan

Osijek

Moscow

Saint Petersburg

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00223977 - 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. | Biotech Hunter | Biotech Hunter